Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Eli Lilly
LLY
|
$534M |
| 2 |
Amazon
AMZN
|
$432M |
| 3 |
Abbott
ABT
|
$420M |
| 4 |
Adobe
ADBE
|
$365M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$277M |
Top Sells
| 1 |
Sherwin-Williams
SHW
|
$472M |
| 2 |
Bank of America
BAC
|
$426M |
| 3 |
TE Connectivity
TEL
|
$399M |
| 4 |
Atlassian
TEAM
|
$364M |
| 5 |
Goldman Sachs
GS
|
$348M |
Sector Composition
| 1 | Technology | 32.59% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.8% |
| 4 | Industrials | 9.76% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
STER
2226
DELISTED
Sterling Check Corp. Common Stock
STER
| $305K | ﹤0.01% |
21,905
-260
| -1% | -$3.62K |
|
2227
Southern Missouri Bancorp
SMBC
$648M
| $305K | ﹤0.01% |
5,715
-8
| -0.1% | -$426 |
|
2228
Smith & Wesson
SWBI
$388M
| $304K | ﹤0.01% |
22,423
-37
| -0.2% | -$502 |
|
|
PETQ
2229
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $303K | ﹤0.01% |
+15,338
| New | +$303K |
|
2230
ImmunityBio
IBRX
$2.27B
| $303K | ﹤0.01% |
60,515
-1
| -0% | -$5 |
|
2231
Douglas Dynamics
PLOW
$771M
| $302K | ﹤0.01% |
10,166
-18
| -0.2% | -$535 |
|
2232
Corsair Gaming
CRSR
$937M
| $302K | ﹤0.01% |
21,389
-32
| -0.1% | -$451 |
|
|
BRSP
2233
BrightSpire Capital
BRSP
$772M
| $301K | ﹤0.01% |
40,418
-47
| -0.1% | -$350 |
|
2234
Atlanticus Holdings
ATLC
$1.03B
| $301K | ﹤0.01% |
+7,768
| New | +$301K |
|
2235
Anavex Life Sciences
AVXL
$807M
| $300K | ﹤0.01% |
32,209
-64
| -0.2% | -$596 |
|
2236
HealthStream
HSTM
$834M
| $299K | ﹤0.01% |
11,069
-21
| -0.2% | -$568 |
|
2237
IDT Corp
IDT
$1.64B
| $298K | ﹤0.01% |
+8,761
| New | +$298K |
|
2238
Genie Energy
GNE
$404M
| $297K | ﹤0.01% |
+10,567
| New | +$297K |
|
2239
Amplitude
AMPL
$1.51B
| $295K | ﹤0.01% |
23,188
-14
| -0.1% | -$178 |
|
2240
Bank First Corp
BFC
$1.26B
| $294K | ﹤0.01% |
3,386
-1,896
| -36% | -$165K |
|
2241
Univest Financial
UVSP
$898M
| $293K | ﹤0.01% |
13,327
-24
| -0.2% | -$528 |
|
2242
Denny's
DENN
$237M
| $292K | ﹤0.01% |
26,863
-55
| -0.2% | -$598 |
|
2243
Cantaloupe
CTLP
$792M
| $291K | ﹤0.01% |
39,308
+12,903
| +49% | +$95.5K |
|
2244
Viridian Therapeutics
VRDN
$1.53B
| $291K | ﹤0.01% |
13,364
-31
| -0.2% | -$675 |
|
|
GMRE
2245
Global Medical REIT
GMRE
$508M
| $290K | ﹤0.01% |
26,146
-50
| -0.2% | -$555 |
|
2246
Stem
STEM
$117M
| $290K | ﹤0.01% |
3,743
-5
| -0.1% | -$387 |
|
2247
ANI Pharmaceuticals
ANIP
$2.07B
| $290K | ﹤0.01% |
5,258
-11
| -0.2% | -$607 |
|
2248
QuinStreet
QNST
$920M
| $289K | ﹤0.01% |
22,584
-43
| -0.2% | -$551 |
|
|
EFC
2249
Ellington Financial
EFC
$1.38B
| $289K | ﹤0.01% |
22,739
-51
| -0.2% | -$648 |
|
2250
Travere Therapeutics
TVTX
$1.93B
| $289K | ﹤0.01% |
32,180
-55
| -0.2% | -$494 |
|